PF-07284890
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PF-07284890, covering 2024-03-15 to 2025-10-23. Get the full timeline:
Most recent: Clinical Trial Update: A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement [Phase 1]